Clinical Trials

A Phase I, Open-Label, Dose-Escalation Study of SEA-CD40 in Adult patients with advanced malignancies


Study ID
Seattle Genetics SGNS40-001

NCT Number
NCT02376699 (Click on the NCT number for more information about the trial)

Research Study Number
2016-0524

Principle Investigator
Dr. Martin Gutierrez

Phase
I

Sponsor
Seattle Genetics


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now